Of every NIH dollar spent on conditions affecting only women
Of autoimmune disease patients are women, yet research remains underfunded
Women were largely excluded from US clinical trials until the 1993 NIH Revitalization Act
Average time to diagnose endometriosis, affecting 1 in 10 women
For most of modern medical history, the default research subject was male. Drug trials, disease models, diagnosticcriteria, all built around male physiology, with the assumption that results would simply transfer. They often don't.
Women metabolise drugs differently. They have different cardiac symptoms. Different pain presentations. Differentresponses to the same treatments. When the research baseline ignores that, the medicine built on top of it ignores ittoo.
The NIH Revitalization Act of 1993 finally mandated that women be included in clinical trials. That was 30 years ago.And we're still catching up.
As a biochemist, Chloe knows this gap isn't just a research problem, it's a communication failure. Science exists. Thedata exists. What's missing is enough people understanding the scope of it, patients, policymakers, donors, andresearchers who can actually do something about it. That's what this page is for.
Up to 90% of menstruating people experience painful periods yet the mechanisms behind it are still poorly understood and routinely dismissed in clinical settings.
190 million people worldwide. No non surgical diagnostic test. A 7-10 year average wait for diagnosis. The funding doesn't come close to matching the scale of the problem.
The last truly new class of female contraception was developed in the 1960s. Decades of reported side effects later, next generation options are still waiting for serious investment.
One of the most common endocrine disorders in women, affecting fertility, metabolism, cardiovascular health, and mental health. Still frequently misdiagnosed. Still significantly underfunded.
Every woman who lives long enough will experience it. Yet research into its cognitive, cardiovascular, and hormonal impacts remains sparse, set back further by a single flawed study that shaped policy for decades.
Women represent 80% of autoimmune disease patients. Lupus, rheumatoid arthritis, multiple sclerosis, diagnosed late, funded less, and still poorly understood at the biological level.
Women led research in women's health consistently measures different endpoints, includes different populations, and asks questions male led teams historically haven't thought to ask
Female physicians are more likely to correctly identify and treat conditions like cardiac events in women, because representation changes clinical instinct, not just research design
Gender diverse research teams produce higher impact science across all fields, not just in women's health
Girls who don't see themselves in science don't pursue it. Researchers who don't see women's health as prestigious don't study it. Funders who don't understand the gap don't close it
Medical AI trained on historically male skewed datasets risks automating the gender health gap into future diagnostics, making representation in data as urgent as representation in labs
Who tries changes who succeeds. Who succeeds changes what gets studied. Changing the face of science isn't symbolic, it's how the research gap actually closes
Day 16 Women in Science – Jane Goodall
Day 15 Women in Science – Shirley Meng The brain drain 🧠is real and...
If you want to be like Marie Curie, I’ve partnered with @polishembassyus to share...
Women in Science Day 12 – Inge Lehmann 🌍 a belated happy earth day!
Day 11 Women in Science – Gladys West
Women in science day 10 – Henrietta Lacks
Day 9 women in science – Grace Hopper 👩💻🛳️
Day 5 women (in science) history month – Dorothy Crowfoot Hodgkin
Day 4 women (in science) history month – Wangarĩ Maathai
Day 3 Women (in Science) History Month – Dr. Vera Rubin Ever wondered where...
Day 2 Women (in science) History Month – Tu Youyou 🙌 integrating Chinese medicine...
Kicking off Women (in science) History Month with Jennifer Doudna — the biochemist who...
